§ 71-7-101. Tennessee Rare Disease Advisory Council
There is established the Tennessee rare disease advisory council, referred to in this chapter as the “advisory council”, to advise the TennCare prescription drug utilization review committee referred to in this chapter as the “DUR”, the TennCare pharmacy advisory committee referred to in this chapter as the “PAC”, and other public and private agencies in […]
§ 71-7-102. Members of Rare Disease Advisory Council — Meetings — Administrative Attachment
The advisory council is administratively attached to the bureau of TennCare, and is composed of eleven (11) members as follows: The governor shall appoint: One (1) representative from the bureau of TennCare; Two (2) representatives from academic research institutions in this state that receive grant funding for rare disease research; Two (2) physicians licensed and […]
§ 71-7-103. Rare Disease Advisory Council Recommendations — Use of Information — Input of Advisory Council
The Tennessee rare disease advisory council shall advise the DUR, the PAC, and other state entities in their review of products or medications for the treatment of rare and orphan diseases, and drugs or biological products within the emerging fields of personalized medicine and non-inheritable gene editing therapeutics. All advisory council recommendations must be presented […]